Targeting IL-6 and it’s signaling pathways could reduce chronic inflammation and potentially restore immune balance in IDD. The dual role of IL-6 necessitates careful modulation to avoid adverse effects on tissue repair. Here, IL6 is linked to intervertebral disk degenerative disorder.